SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001047469-16-016210
Filing Date
2016-10-21
Accepted
2016-10-21 16:37:10
Documents
5

Document Format Files

Seq Description Document Type Size
1 F-3 a2230061zf-3.htm F-3 323958
2 EX-5.1 a2230061zex-5_1.htm EX-5.1 57533
3 EX-23.1 a2230061zex-23_1.htm EX-23.1 3792
4 G881334.JPG g881334.jpg GRAPHIC 8272
5 G202552KGI001.GIF g202552kgi001.gif GRAPHIC 3262
  Complete submission text file 0001047469-16-016210.txt   402376
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-214197 | Film No.: 161946572
SIC: 2834 Pharmaceutical Preparations